420 with CNW — New Device Could Provide More Accuracy in Measuring Cannabis Impairment

The use of marijuana, whether for medicinal or recreational purposes, has grown rapidly within the United States during the past few years. This growth is said to be due to the wave of legalizations that has swept through several states as well as the changing public attitudes towards this controversial plant. The growing use of marijuana has presented a huge challenge to both law enforcement agencies and employers as they work to detect and prevent cannabis impairment on the roads and at workplaces.

Many have looked to breathalyzers to provide a way to quickly identify someone who is acting under the influence of cannabis. Breathalyzers are familiar technology, and they are easy to use in the field. However, there is currently no verifiable way to link the presence of THC metabolites in the body to a degree of impairment.

This challenge stems from two key factors. First, THC can remain detectable in someone’s body several weeks after they consume marijuana, so a positive test for THC isn’t reliable evidence that a person is impaired. Secondly, different people respond differently when they use marijuana, so having a certain concentration of marijuana in the blood (or whatever sample has been analyzed) isn’t proof beyond reasonable doubt that an individual is impaired.

A new impairment test looks set to settle this debate on how to assess cannabis impairment once and for all. The artificial intelligence (AI)- and VR (virtual reality)-based device is focused on measuring actual impairment rather than on detecting how much THC is present in an individual’s blood, saliva or other biological sample.

The Gaize Cannabis Impairment Test, developed by Gaize AI, seeks to provide video evidence to confirm or rule out marijuana impairment. The person being tested wears a VR headset and performs half a dozen tasks as sensors on the headset monitor the eye movements of the test subject. The logic behind this test is that every substance has a different effect on the eye movements of a person. The tests require approximately five minutes, with an additional two minutes needed to crunch the numbers and provide the results of the impairment test.

Ken Fichtler, founder and CEO of the company, says that his system is up to 90% accurate in detecting impairment, and the machine learning tech it runs on can allow the system to improve its degree of accuracy. He thinks that once the device is widely deployed, the hurdle of getting marijuana federally legalized could be reduced since one of the current challenges in the way of legalization is the difficulty of measuring impairment.

The handy device can also be used to test employees just before their shifts begin, so there is a lot of potential for the usability of this impairment test. These more precise testing methods could enjoy the support of the marijuana industry and its actors such as American Cannabis Partners because the accuracy tests would eliminate the possibility of people being unfairly victimized for using recreational or medical marijuana several days or even months before they were tested.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Upcoming Cannabis Landscape Webinar, Launches Highsman Helix

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, is hosting a webinar focused on the global cannabis regulatory landscape; the event is scheduled for Thursday, May 19, at 4 p.m. EDT. Titled “The State of the Play: Cannabis Regulatory Landscape,” the webinar will feature Flora Growth executives, including president and CEO Luis Merchan, COO Jason Warnock and newly appointed VP of regulatory affairs Holly Bell. The webinar agenda includes an overview of the opportunities and challenges facing Flora and other cannabis companies operating in the United States, Colombia and other global markets; the importance of working closely with government entities will also be discussed. In addition, Bell will be speaking at Florida’s Industrial Hemp Conference and Exhibition, slated for May 20, 2022. This premier event explores the progress of the industrial hemp industry in Florida and across the United States. Bell will discuss Florida’s hemp program, which she worked with state regulators to develop. Flora Growth also announced that Vessel, its cannabis accessories brand, is partnering with Highsman. A cannabis lifestyle brand, Highsman was created by former NFL running back Ricky Williams to celebrate greatness. The first offering from the partnership is a custom Highsman-branded and designed Helix one-hitter accessory made from pure, nontoxic brass. The design, which is patent pending, features an ideal combination of filtering and cooling. “Ricky Williams’ distinct personal style is reflected in the unique design of the Highsman Helix,” said Flora Growth chief strategy officer and Vessel president James Choe in the press release. “Ricky’s story personifies the authenticity and individuality that exists at the core of Vessel, and this collaboration is a true representation of the freedom to be original.”

To register for the webinar, visit https://cnw.fm/wIlHF

To register for the conference, visit https://cnw.fm/ygLm2

To view the full press releases, visit https://cnw.fm/ytmqt and https://cnw.fm/kA1Zc

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands designed to deliver the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands and life sciences divisions. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Releases Status Update Regarding MCTO

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has shared a status update on the management cease trade order (“MCTO”) the company received from the British Columbia Securities Commission; the MCTO was effective on May 3, 2022, under the National Policy 12-203. In the update, the company references its original press release, which announced a delay in the filing of key financial statements and accompanying management’s discussion and analysis for FY 2021, a delay that would extend beyond the period outlined in the applicable Canadian securities laws. The update also noted that progress is being made with the audit, as well as with the completion of RWB’s interim financial statements and accompanying management’s discussion and analysis for Q1 2022. Based on market regulations, the general investing public may continue to trade in the company’s listed commons shares during the MCTO, although Red White & Bloom’s CEO and interim CFO are not allowed to trade company shares. The status update confirmed that the company is working to satisfy the provisions of NP 12-203, including providing biweekly status reports.

To view the full press release, visit https://cnw.fm/4tJyq

About Red White & Bloom Brands Inc.

Red White & Bloom is a multistate cannabis operator and house of premium brands in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Arizona, California, Florida, Illinois, Massachusetts and Michigan with respect to cannabis, and the United States and internationally for hemp-based CBD products. For more information about the company, please visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

NECANN Illinois Cannabis Convention

Date: June 10-11, 2022
Venue: McCormick Lakeside Center, 2301 S. Lake Shore Drive, Chicago, IL
Exhibit Hall Hours
10:00 AM – 4:00 PM

The 2nd annual NECANN Illinois Cannabis Convention is scheduled for June 10-11, 2022, at the McCormick Lakeside Center, 2301 S. Lake Shore Drive, Chicago, IL
The event promises an excellent resource for the cannabis industry and a platform for stakeholders to connect, learn and grow together
This convention is ideal for those looking to launch a new cannabis business, start a new career in the cannabis space, or promote their existing cannabis business

All stakeholders in the Illinois cannabis space are invited to the 2022 Illinois Cannabis Convention scheduled for June 10-11, 2022. The event, hosted by NECANN, promises to be an excellent resource hub for the rapidly expanding cannabis industry and a platform for patients, businesses, educators, investors, entrepreneurs, and consumers to connect, learn and grow together.

Over 40 industry professionals will present at the event, covering various topics such as building and running a sustainable business, how to successfully land free earned media, tissue culture, and cybersecurity priorities for the cannabis industry.

This will be NECANN’s 2nd convention this year after producing the New England Cannabis Convention this past March. NECANN has 4 more conventions this year:

Vermont: June 25-26
New York: August 26-27
New Jersey: September 9-10
Maine: September 24-25

To know more, please visit https://cnw.fm/uTMMo.

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — NIH to Fund Studies Exploring Marijuana’s Role in Cancer Treatment

The National Institutes of Health (NIH) has published a notice calling on interested researchers to apply for funding to facilitate studies related to the role cannabis can play in various aspects of cancer treatment. In that notice, the federal agency revealed that one out of every four patients with cancer report using marijuana products in order to manage the symptoms they experience. These symptoms include pain, nausea and anorexia. However, NIH points out that despite these reasons for using marijuana, there is scant research about its efficacy and any potential risks that the cancer patients may be exposing themselves to.

The funding is therefore intended to promote studies geared at understanding the different mechanisms through which cannabinoids and cannabis in general influence cancer biology, interception and treatment as well as cancer resistance. Studies looking into oncology symptom management also qualify for the federal funding.

The notice also delves into an overview of existing studies exploring marijuana’s relationship with cancer. According to the NIH, the present epidemiological studies on cancer and marijuana haven’t yielded consistent or definitive findings. For instance, some studies suggest that smoking marijuana exposes an individual to harmful compounds, but no study has so far been able to demonstrate a link between smoking marijuana and increased cases of lung cancer.

The National Institutes of Health also provides eight areas of interest that qualify for funding by the federal agency. These include how ethnicity or sex disparities manifest when cannabinoids and marijuana are being used to treat cancer or manage the symptoms triggered by cancer treatment; developing relevant study models through which a better understanding of the role of marijuana in cancer treatment can be attained; and defining the exact effects that marijuana/cannabinoids have on the treatment of cancer, among other study areas.

There is a rider stipulating that the list of eight items isn’t exhaustive and that scientists looking into any other aspect of marijuana in the treatment of cancer can apply, especially those planning to make use of expertise drawn from diverse disciplines and those making use of highly rated study models that are relevant to humans.

Despite the federal government’s insistence that marijuana remains classified under Schedule 1 of the CSA, many federal agencies are intensifying their efforts in supporting research aimed at documenting the therapeutic effects and possible side effects of marijuana. Such federally funded studies could go a long way toward gathering evidence that can be used to push for a reclassification or even legalization of cannabis, at least for medicinal purposes.

As more data becomes available about the therapeutic effects of marijuana, companies that make products easing the cultivation of this and other plants, such as Advanced Container Technologies Inc. (OTC: ACTX), could register a surge in demand as more jurisdictions permit cannabis home grows.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — IRS Official Discusses Cannabis Sector’s Current Financial Challenges

The U.S. IRS Taxpayer Advocate, an agency under the Internal Revenue Service (IRS), has published a blog post in which the agency discusses the tax obligations that marijuana companies have and the efforts which are being taken at the Congressional level to resolve some of those challenges.

The blog post pointed out that, although companies in the cannabis industry are expected to meet their federal tax obligations, the firms aren’t at liberty to deduct many of the expenses that firms in other industries normally deduct when determining their tax obligations. This disparity stems from the fact that under federal law, marijuana is a controlled substance that cannot be bought or sold legally, so businesses engaged in cannabis business can’t claim tax deductions on an illegal activity.

Erin Collins, the National Tax Advocate (NTA) who penned the post, wasn’t committal about any changes to policy that needed to be made. However, she did acknowledge that Congress was making efforts to enact marijuana legalization or at the very least offer protections to banks that opt to do business with marijuana companies at state level.

The reason for posting this article, according to the author, was to highlight some of the increasing frustrations that a notable and growing category of taxpayers, including marijuana growers, processors, distributors as well as retailers, face. Educating these taxpayers was also a focus of the post.

The NTA wrote that tax code 280E is unequivocal in precluding businesses that “traffic marijuana” from taking advantage of many tax deductions enjoyed by other businesses that the federal government regards as legal. Because of this provision, Collins says that businesses in the marijuana industry end up meeting their tax obligations from their gross earnings rather than from their net income as would ordinarily be the case.

Another challenge facing the cannabis industry is the limited number of IRS locations that can receive cash payments. Businesses not only have to arrange to transport such large sums of cash, but they also have to move long distances in order to access the specific IRS sites capable of accepting large cash payments to clear tax obligations.

As a result of the high tax rate and the limitations on what business expenses can be deducted, it is significantly harder for a marijuana business to reach break-even point in its operations, the post says. The article also mentions that since marijuana isn’t federally recognized as a medicine, people can’t deduct medical marijuana costs as they file their annual tax returns.

The issues raised in this NTA article are known all too well by established marijuana companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) that have, through dogged determination, managed to find a measure of success despite those huge odds stacked against the industry.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – AmeriCann (ACAN) Announces Positive Quarterly Results, Operations Update

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, today released financial and operational results for its fiscal quarter ending March 31, 2022. According to the update, the company achieved a significant increase in year-over-year quarterly revenue, culminating in positive net income for the quarter. Revenue from operations increased over 52% for the quarter ended March 2022 relative to the same quarter in 2021, an increase of $230,021. AmeriCann set an all-time monthly record in revenue for April 2022 and attributes the increase in financial performance to greater revenue received from products produced and manufactured at Building 1, the company’s initial building at its Massachusetts Cannabis Center development in Freetown, Massachusetts. “The success we have achieved with Building 1 is a testament to the quality of consistent products being produced for patients and consumers,” said AmeriCann CEO and President Tim Keogh. “The increased revenue, margins and profits we have achieved validates our vision for the Massachusetts Cannabis Center and our expansion plans.”

To view the full press release, visit https://cnw.fm/3aSiK

About AmeriCann

AmeriCann develops and leases cannabis cultivation, processing and product manufacturing facilities. AmeriCann uses greenhouse technology, which is superior to the current industry standard of growing cannabis in warehouse facilities under artificial lights. According to industry experts, by capturing natural sunlight, greenhouses use 25% fewer lights, and utility bills are up to 75% less than in typical warehouse cultivation facilities. As such, AmeriCann’s Cannopy System enables cannabis to be produced with a greatly reduced carbon footprint, making the final product less expensive. Additionally, greenhouse construction costs are nearly half of warehouse construction costs. AmeriCann is also designing GMP-Certified cannabis extraction and product manufacturing infrastructure. AmeriCann has secured licenses to produce cannabis-infused products including beverages, edibles, topicals and concentrates. AmeriCann plans to operate a marijuana product manufacturing business at the Massachusetts Cannabis Center. For more information about the company, visit www.AmeriCann.co.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Flora Growth Corp. (NASDAQ: FLGC) Bolsters its Board of Directors following Tim Leslie’s Addition and Luis Merchan’s Appointment as Chairman

Luis Merchan, Flora Growth’s CEO, will serve as the new Chairman of the Board
Tim Leslie, the Chairman of the company’s Advisory Board, will serve on its Board and audit committee
Flora Growth’s management is confident that these changes will position it as a U.S-based issuer while increasing its access to U.S-based investment

Since the beginning of 2022, Flora Growth (NASDAQ: FLGC) has been making strategic moves that strengthen its human resources and reinforce its executive team.

The company kicked off the year with the appointment of Tim Leslie as the Chairman of its newly formed Advisory Board (https://cnw.fm/suiqd). Later, Flora Growth appointed Derek Pedro, a world-renowned cannabis genetics and cultivation expert, as an advisor to its Cosechemos cultivation facility (https://cnw.fm/w5nCn).

Two more appointments were made after that, starting with Joël Reyes as Senior Vice President (“SVP”) of Global Operations and Jessie Casner as the company’s new Chief Marketing Officer (“CMO”) (https://cnw.fm/Gz7Ez).

In a move that sought to take the company even further, on March 17, 2022, Flora Growth announced changes to its Board of Directors. Tim Leslie, the Chairman of the Advisory Board, was added to the Board of Directors (“the Board”) and audit committee. In addition, Luis Merchan, Flora Growth’s Chief Executive Officer (“CEO”), took over from Bernie Wilson as the Chairman of the Board. Mr. Wilson will remain in an advisory capacity for the remainder of the year and will be integral in providing strategic guidance on capital markets and international expansion (https://cnw.fm/NywYv).

“I am honored that our Board has entrusted me with this role, and I believe it is a testament to what we have built together thus far,” noted Luis Merchan.

“Our Board has been incredibly supportive to date while always ensuring business decisions are in the best interest of our shareholders- and I am looking forward to continuing to work closely with them in this role,” he added.

Luis Merchan has been instrumental in expanding Flora Growth’s reach within the United States and abroad. He has moved the company from the development stage to a full-scale international distributor with operations in over 12 countries worldwide. In addition, under his leadership, Flora Growth has completed several mergers and acquisitions (“M&As”), all of which have set the company up for rapid growth.

The company will continue to benefit from Mr. Leslie’s insights and guidance as it advances its rapid global expansion. He has vast experience in the industry, including two decades at Amazon, which will be instrumental for Flora Growth’s expansion going forward.

Flora Growth is confident that its Board’s changes will further position it as a U.S-based issuer. It is also optimistic that the move will increase its access to U.S-based investment.

For more information, visit the company’s website at www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Sugarmade Inc. (SGMD) Announces Key Agreements that Solidify Company Strategy, Success Moving Forward

SGMD enters into a definitive agreement designed to expand its cannabis delivery footprint
Company inks deal to establish a minority stake in an expanding reservation-only restaurant brand that includes private event space offering cannabis consumption
Sugarmade also partners with BHG to be first-choice cannabis provider

The cannabis space is known for its competition, but Sugarmade (OTC: SGMD), an emerging leader in the sector, has distinguished itself by its smart, creative decisions. Sugarmade has once again showed its expertise in savvy business strategy by announcing plans to establish a new hub for cannabis delivery and partnering with an expanding reservation-only restaurant brand with an adjacent private event space that offers cannabis consumption (https://cnw.fm/q3HzS).

Last month Sugarmade entered into a definitive agreement designed to expand its cannabis delivery footprint. The agreement established SGMD’s majority ownership in a fully licensed new Hollywood cannabis delivery hub located on the world-famous Sunset Strip. Based on the agreement, the company will receive 100% of all profits from the new delivery hub until it has made back its capital investment; following that, Sugarmade will receive 51% of profits.

The new cannabis retail distribution hub will offer delivery to the affluent neighborhoods of the West Hollywood Hills. “This investment lands us on the ground floor of a new concept for cannabis distribution in the world’s biggest cannabis marketplace,” said Sugarmade CEO Jimmy Chan.

In addition to the cannabis delivery agreement, Sugarmade also inked a deal to establish a minority stake in an expanding reservation-only restaurant brand with a unique feature: the establishment includes an adjacent private event space that offers cannabis consumption. The restaurant is also located on Sunset Strip.

In addition, the company partnered with Boulevard Hospitality Group, which is best known for operating Yamashiro, an iconic Hollywood Hills restaurant that is more than a century old. This collaboration calls for Sugarmade to be the first-choice provider of cannabis as BHG explores opportunities to open cannabis-only venues.

“Through these agreements, we are simultaneously adding a new cannabis end market with future growth potential, doubling our delivery coverage in the LA metro area, and creating a new and more diversified revenue profile,” said Chan. “We believe all of these steps represent strong potential drivers for shareholder value.”

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush, NUG Avenue and Lemon Glow.

For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SGMD

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Thai Government to Distribute Marijuana Plants for Home Cultivation

The government in Thailand has announced that it plans to distribute one million free marijuana plants in June as it marks the commencement of a new law permitting the cultivation of marijuana at home. This announcement was made by the nation’s health minister.

Anutin Charnvirakul, Thailand’s health minister, took to Facebook to make his announcement on May 8, 2022. He said that the government wants marijuana to be grown like any other household crop.

The rule he referred to is expected to take effect on June 9, 2022. This new legislation paves the ground for individuals to notify the authorities in their locality about their need to start growing cannabis at home. The plants must meet the quality requirements for medicinal marijuana, and the person growing those plants should use them exclusively for therapeutic purposes and not for commerce. Those interested in growing marijuana for sale can apply for additional permits from the authorities.

The soon-to-be implemented law marks another step in Thailand’s journey to promote the cultivation of marijuana like any other cash crop. The World Bank estimates that approximately 33% of the population in the country is employed within the agriculture sector, so adding marijuana to the list of crops farmers can grow would be a boon for the sector.

It should be noted that the broader southeast Asian region is famous for its stringent laws against illicit drugs, such as marijuana. However, Thailand broke ranks and legalized medicinal marijuana back in 2018. The country has also eased its other laws related to cannabis in general.

For example, cannabidiol and hemp in general were legalized for use as food and cosmetics ingredients. As a result there has been a proliferation of companies marketing cosmetics and beverages containing these ingredients.

In another post made two days after his post announcing the free marijuana plants, Anutin also mentioned that locally registered companies that had the appropriate paperwork were free to begin selling marijuana products as long as the THC content didn’t exceed 0.2%. THC is the compound that gets cannabis users “high.”

Anutin added that marijuana commerce will make it possible for the country to earn at least 10bn baht ($288 million) annually from this industry.

Kitty Chopaka, a marijuana entrepreneur based in Bangkok, indicated that in her view, this upcoming legislation is intended to make medical cannabis part of the healthcare system in the country. According to her, one must have a prescription allowing the use of medicinal marijuana in order to be permitted to grow cannabis at home. She further indicated that while recreational adult-use cannabis isn’t legal, people are bound to smoke the substance and the government won’t be able to prevent that from happening.

With Thailand due to begin commercial sales of medical marijuana, more of the world looks set to open to international cannabis sector actors such as Flora Growth Corp. (NASDAQ: FLGC), one country at a time.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.